Copyright Reports & Markets. All rights reserved.

Global Antidepressant Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Antidepressant Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Antidepressant Drugs Market Size Growth Rate by Product
      • 1.4.2 Major Depressive Disorder
      • 1.4.3 Obsessive-Compulsive Disorder
      • 1.4.4 Generalized Anxiety Disorder
      • 1.4.5 Panic Disorder
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Antidepressant Drugs Market Size Growth Rate by End User
      • 1.5.2 Tricyclic Antidepressants
      • 1.5.3 Selective Serotonin Reuptake Inhibitors
      • 1.5.4 Serotonin-norepinephrine reuptake Inhibitors
      • 1.5.5 Monoamine oxidase inhibitors
      • 1.5.6 Serotonin antagonist and reuptake inhibitors
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Antidepressant Drugs Market Size
      • 2.1.1 Global Antidepressant Drugs Revenue 2014-2025
      • 2.1.2 Global Antidepressant Drugs Sales 2014-2025
    • 2.2 Antidepressant Drugs Growth Rate by Regions
      • 2.2.1 Global Antidepressant Drugs Sales by Regions
      • 2.2.2 Global Antidepressant Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Antidepressant Drugs Sales by Manufacturers
      • 3.1.1 Antidepressant Drugs Sales by Manufacturers
      • 3.1.2 Antidepressant Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Antidepressant Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antidepressant Drugs Revenue by Manufacturers
      • 3.2.1 Antidepressant Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Antidepressant Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Antidepressant Drugs Price by Manufacturers
    • 3.4 Antidepressant Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Antidepressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Antidepressant Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Antidepressant Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Antidepressant Drugs Sales by Product
    • 4.2 Global Antidepressant Drugs Revenue by Product
    • 4.3 Antidepressant Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Antidepressant Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Antidepressant Drugs by Countries
      • 6.1.1 North America Antidepressant Drugs Sales by Countries
      • 6.1.2 North America Antidepressant Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Antidepressant Drugs by Product
    • 6.3 North America Antidepressant Drugs by End User

    7 Europe

    • 7.1 Europe Antidepressant Drugs by Countries
      • 7.1.1 Europe Antidepressant Drugs Sales by Countries
      • 7.1.2 Europe Antidepressant Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Antidepressant Drugs by Product
    • 7.3 Europe Antidepressant Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Antidepressant Drugs by Countries
      • 8.1.1 Asia Pacific Antidepressant Drugs Sales by Countries
      • 8.1.2 Asia Pacific Antidepressant Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Antidepressant Drugs by Product
    • 8.3 Asia Pacific Antidepressant Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Antidepressant Drugs by Countries
      • 9.1.1 Central & South America Antidepressant Drugs Sales by Countries
      • 9.1.2 Central & South America Antidepressant Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Antidepressant Drugs by Product
    • 9.3 Central & South America Antidepressant Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Antidepressant Drugs by Countries
      • 10.1.1 Middle East and Africa Antidepressant Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Antidepressant Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Antidepressant Drugs by Product
    • 10.3 Middle East and Africa Antidepressant Drugs by End User

    11 Company Profiles

    • 11.1 Alkermes
      • 11.1.1 Alkermes Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alkermes Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alkermes Antidepressant Drugs Products Offered
      • 11.1.5 Alkermes Recent Development
    • 11.2 Allergan
      • 11.2.1 Allergan Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Allergan Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Allergan Antidepressant Drugs Products Offered
      • 11.2.5 Allergan Recent Development
    • 11.3 Bristol Myers Squibb
      • 11.3.1 Bristol Myers Squibb Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bristol Myers Squibb Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bristol Myers Squibb Antidepressant Drugs Products Offered
      • 11.3.5 Bristol Myers Squibb Recent Development
    • 11.4 Eli Lilly
      • 11.4.1 Eli Lilly Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Eli Lilly Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Eli Lilly Antidepressant Drugs Products Offered
      • 11.4.5 Eli Lilly Recent Development
    • 11.5 GlaxoSmithKline
      • 11.5.1 GlaxoSmithKline Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 GlaxoSmithKline Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 GlaxoSmithKline Antidepressant Drugs Products Offered
      • 11.5.5 GlaxoSmithKline Recent Development
    • 11.6 Lundbeck
      • 11.6.1 Lundbeck Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Lundbeck Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Lundbeck Antidepressant Drugs Products Offered
      • 11.6.5 Lundbeck Recent Development
    • 11.7 Merck
      • 11.7.1 Merck Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merck Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merck Antidepressant Drugs Products Offered
      • 11.7.5 Merck Recent Development
    • 11.8 Pfizer
      • 11.8.1 Pfizer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Pfizer Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Pfizer Antidepressant Drugs Products Offered
      • 11.8.5 Pfizer Recent Development
    • 11.9 Teva
      • 11.9.1 Teva Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Teva Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Teva Antidepressant Drugs Products Offered
      • 11.9.5 Teva Recent Development
    • 11.10 Takeda
      • 11.10.1 Takeda Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Takeda Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Takeda Antidepressant Drugs Products Offered
      • 11.10.5 Takeda Recent Development

    12 Future Forecast

    • 12.1 Antidepressant Drugs Market Forecast by Regions
      • 12.1.1 Global Antidepressant Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Antidepressant Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Antidepressant Drugs Market Forecast by Product
      • 12.2.1 Global Antidepressant Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Antidepressant Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Antidepressant Drugs Market Forecast by End User
    • 12.4 North America Antidepressant Drugs Forecast
    • 12.5 Europe Antidepressant Drugs Forecast
    • 12.6 Asia Pacific Antidepressant Drugs Forecast
    • 12.7 Central & South America Antidepressant Drugs Forecast
    • 12.8 Middle East and Africa Antidepressant Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Antidepressant Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression.
      The global Antidepressant Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antidepressant Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Antidepressant Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidepressant Drugs in these regions.
      This research report categorizes the global Antidepressant Drugs market by top players/brands, region, type and end user. This report also studies the global Antidepressant Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alkermes
      Allergan
      Bristol Myers Squibb
      Eli Lilly
      GlaxoSmithKline
      Lundbeck
      Merck
      Pfizer
      Teva
      Takeda

      Market size by Product
      Major Depressive Disorder
      Obsessive-Compulsive Disorder
      Generalized Anxiety Disorder
      Panic Disorder
      Others
      Market size by End User
      Tricyclic Antidepressants
      Selective Serotonin Reuptake Inhibitors
      Serotonin-norepinephrine reuptake Inhibitors
      Monoamine oxidase inhibitors
      Serotonin antagonist and reuptake inhibitors
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Antidepressant Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Antidepressant Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Antidepressant Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Antidepressant Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Antidepressant Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antidepressant Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now